Pregledni rad
Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?
Igor Tomašković
Puni tekst: hrvatski pdf 96 Kb
str. 51-56
preuzimanja: 417
citiraj
APA 6th Edition
Tomašković, I. (2015). Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?. Medicus, 24 (1 Urologija), 51-0. Preuzeto s https://hrcak.srce.hr/144634
MLA 8th Edition
Tomašković, Igor. "Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?." Medicus, vol. 24, br. 1 Urologija, 2015, str. 51-0. https://hrcak.srce.hr/144634. Citirano 21.11.2024.
Chicago 17th Edition
Tomašković, Igor. "Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?." Medicus 24, br. 1 Urologija (2015): 51-0. https://hrcak.srce.hr/144634
Harvard
Tomašković, I. (2015). 'Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?', Medicus, 24(1 Urologija), str. 51-0. Preuzeto s: https://hrcak.srce.hr/144634 (Datum pristupa: 21.11.2024.)
Vancouver
Tomašković I. Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?. Medicus [Internet]. 2015 [pristupljeno 21.11.2024.];24(1 Urologija):51-0. Dostupno na: https://hrcak.srce.hr/144634
IEEE
I. Tomašković, "Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?", Medicus, vol.24, br. 1 Urologija, str. 51-0, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/144634. [Citirano: 21.11.2024.]
Puni tekst: engleski pdf 96 Kb
preuzimanja: 909
citiraj
APA 6th Edition
Tomašković, I. (2015). Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?. Medicus, 24 (1 Urologija), 51-0. Preuzeto s https://hrcak.srce.hr/144634
MLA 8th Edition
Tomašković, Igor. "Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?." Medicus, vol. 24, br. 1 Urologija, 2015, str. 51-0. https://hrcak.srce.hr/144634. Citirano 21.11.2024.
Chicago 17th Edition
Tomašković, Igor. "Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?." Medicus 24, br. 1 Urologija (2015): 51-0. https://hrcak.srce.hr/144634
Harvard
Tomašković, I. (2015). 'Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?', Medicus, 24(1 Urologija), str. 51-0. Preuzeto s: https://hrcak.srce.hr/144634 (Datum pristupa: 21.11.2024.)
Vancouver
Tomašković I. Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?. Medicus [Internet]. 2015 [pristupljeno 21.11.2024.];24(1 Urologija):51-0. Dostupno na: https://hrcak.srce.hr/144634
IEEE
I. Tomašković, "Does Prostate Specific Antigen (PSA) Screening Reduce Prostate Cancer Mortality?", Medicus, vol.24, br. 1 Urologija, str. 51-0, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/144634. [Citirano: 21.11.2024.]
Sažetak
In spite of the fact that prostate cancer is one of the deadliest malignancies in men, the effect of prostate-specific antigen (PSA) screening on prostate cancer mortality remains debated. The European Randomized Study of Screening for Prostate Cancer (ERSPC) demonstrated a statistically significant 27% decrease in prostate cancer-specific mortality after 13 years of follow-up in screened vs. Unscreened men. In contrast, the prostate arm of the US Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) found no benefit from screening. Irrespective of mortality impact, favourable results from prostate cancer screening include an increasing number of men with localised disease and an increase in the number of well-differentiated tumours. However, the risk of overdiagnosis and subsequent overtreatment, including its effects on the quality of life, offers arguments against screening. The present knowledge requires a review of the previous recommendations on the use of PSA.
Ključne riječi
prostate-specific antigen; PSA, screening; early detection; prostate cancer
Hrčak ID:
144634
URI
https://hrcak.srce.hr/144634
Datum izdavanja:
8.9.2015.
Podaci na drugim jezicima:
hrvatski
Posjeta: 2.428
*
